Chemical pharmaceutical is the main industry of China pharmaceutical market, occupying a pivotal position in the pharmaceutical industry. With the improvement of the national economical development and residents’ living standards, the chemical pharmaceutical market gradually expands and the position gradually improves in China. Seen from the industrial gross output value and growth rate, the proportion of industrial output value in GDP has kept increasing with a rapid growth since 2005.
In the long run, because China chemical pharmaceutical industry is still in a relatively backward position, especially the R&D capacities of the original study medicine, in order to ensure medication needs of the broad masses of people and improve the international position of chemical pharmaceutical industry, it still gives strong support to the development of chemical pharmaceutical industry. On the other hand, the domestic demand for drugs still keeps increasing in China. With comprehensive consideration, the position of chemical pharmaceutical industry in the China national economy is expected to further enhance.
The chemical pharmaceutical industry has kept a high level and steady growth rate for recent 6 years, sales revenue of 2011 reaching CNY 715.516 billion and 23.40% growth rate, which is mainly influenced by the good economical development of China, rigid demand of an aging population, the introduction of a series of medical reform policy including increase in the proportion of health insurance reimbursement etc. In 2012, the sales revenue of chemical pharmaceutical was CNY 831.3 billion with 18.98% year-on -year growth. In 2012, the chemical pharmaceutical industry still run high development trend basing on over 90% of production and marketing rate.
It is predicted that this trend is hard to make immediate changes in short terms. It is predicted that the production capacity of the future chemical pharmaceutical industry will continuously enhance and the gross value of industrial output is expected to keep a higher growth.The production capacity of China pharmaceutical companies will also gradually enhance with the expansion of pharmaceutical market. Meanwhile, the chemical pharmaceutical industry face changes of development model and adjustments of industrial structure. For pharmaceutical companies, updating and restructuring is the only way to become bigger and stronger.
See More Reports of This Category by Radiant Insights:
The implementation of the 12th- Five-Year plan of pharmaceutical industry points out the direction for the future development of chemical pharmaceutical industry. As the major industry of the emerging strategic development of the national economy in China, chemical pharmaceutical industry has more developing chances. Over the next 10 years, chemical pharmaceutical industry still face the development chances focusing on the drug price adjustment, structure adjustment, industry consolidation and restructuring and changes of development model. Supporting products, projects and enterprises which are in line with industry trends, will have good investment returns.
Development Research and Investment Value of Sewage Treatment Industry in China, 2013-2017
There are 648 cities establishing sewage treatment plants, accounting for 98.5% of the total number of cities; the cumulative number of sewage treatment plants is 1,947 (increased by 106 compared with the end of 2011); sewage treatment capacity is 117 million cubic meters / day (increased by 4.5 million cubic meters / day). Nine cities have not yet built sewage treatment plants, including Aershsan in Inner Mongolia Autonomous Region, Shangzhi, Wuchang, Mishan, Tieli, and Hailun in Heilongjiang Province, Lincang in Yunnan Province, Xigaze Tibet Autonomous Region, and Wujiaqu City in Xinjiang.
For more infirnation on “Sewage Treatment Industry in China” Visit:
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For more information, Visit: http://www.radiantinsights.com/
Blog URL: http://www.ni2014.org/
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States